FIELD: medicine.
SUBSTANCE: present invention also relates to polynucleotides coding peptides, antigen-presenting cells presenting peptides, and cytotoxic T-cells aimed at peptides, as well as to methods of inducing antigen-presenting cells or CTL. Present invention also relates to compositions and pharmaceutical compositions containing them as an active ingredient. Additionally, the present invention refers to methods of treating and/or preventing a malignant tumour and/or preventing its postoperative relapse using peptides, polynucleotides, antigen-presenting cells, cytotoxic T-cells or pharmaceutical compositions according to the present invention. Methods of inducing an immune response against a malignant tumour are also provided.
EFFECT: invention relates to epitope peptides derived from CDCA1, with the ability to induce cytotoxic T-cells.
18 cl, 12 dwg, 3 tbl, 4 ex
Title |
Year |
Author |
Number |
KOC1-DERVIED PEPTIDE AND VACCINE INCLUDING SAME |
2015 |
- Tsunoda Takuya
- Osawa Ryuji
- Yamashita Sachiko
- Watanabe Tomohisa
- Hikichi Tetsuro
|
RU2699542C2 |
URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME |
2015 |
- Tsunoda, Takuya
- Osawa, Ryuji
- Yamashita, Sachiko
- Watanabe, Tomohisa
- Hikichi, Tetsuro
|
RU2700881C2 |
PEPTIDE, OBTAINED FROM MPHOSPH1, AND INCLUDING ITS VACCINE |
2016 |
- Yamashita, Sachiko
- Hikichi, Tetsuro
|
RU2731099C2 |
PEPTIDE OBTAINED FROM DEPDC1 AND VACCINE CONTAINING IT |
2016 |
- Yamashita, Sachiko
- Hikichi, Tetsuro
|
RU2765574C2 |
PEPTIDE DERIVED FROM FOXM1, AND INCLUDING ITS VACCINE |
2016 |
- Yamashita, Sachiko
- Hikichi, Tetsuro
|
RU2738418C2 |
CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING SAME |
2009 |
- Tsunoda Takuja
- Okhsava Rjudzi
- Josimura Satiko
|
RU2502740C2 |
MODIFIED MELK PEPTIDES AND VACCINES CONTAINING LATTER |
2011 |
- Nakamura Jusuke
- Tsunoda Takuja
- Okhsava Rjudzi
- Josimura Satiko
- Vatanabe Tomokhisa
|
RU2580035C2 |
CDCA1 PEPTIDE AND PHARMACEUTICAL DRUG CONTAINING IT |
2008 |
- Nisimura Jasukharu
- Kharao Mitiko
- Tsunoda Takuja
- Nakamura Jusuke
|
RU2486195C2 |
PHARMACEUTICAL, CONTAINING EPITOPE PEPTIDES HIG2 AND URLC10, FOR CANCER TREATMENT, METHODS AND MEANS FOR INDUCTION OF ANTIGEN-PRESENTING CELL AND CYTOTOXIC T-LYMPHOCYTE (CTL), ANTIGEN-PRESENTING CELL AND CTL, OBTAINED THEREOF, METHOD AND MEANS OF IMMUNE ANTI-CANCER RESPONSE |
2009 |
- Tsunoda Takuja
- Okhsava Rjudzi
- Josimura Satiko
|
RU2529373C2 |
EPITOPIC PEPTIDES RAB6KIFL/KIF20A AND VACCINES CONTAINING THEM |
2009 |
- Nisimura,Jasukharu
- Imai,Katsunori
- Nakamura,Jusuke
- Tsunoda,Takuja
|
RU2532105C2 |